Major Update 2: Remdesivir for Adults With COVID-19

Affiliations

¹ Minneapolis VA Section of Infectious Diseases and University of Minnesota School of Medicine, Minneapolis, Minnesota.
² Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research, and University of Minnesota School of Medicine, Minneapolis, Minnesota.

Free article

Comment

Anjum S Kaka et al. Ann Intern Med. 2022 Aug.

Free article

. 2022 Aug;175(8):W81-W82.

doi: 10.7326/L22-0212.

¹ Minneapolis VA Section of Infectious Diseases and University of Minnesota School of Medicine, Minneapolis, Minnesota.
² Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research, and University of Minnesota School of Medicine, Minneapolis, Minnesota.

No abstract available

Comment on

Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
Kaka AS, MacDonald R, Linskens EJ, Langsetmo L, Vela K, Duan-Porter W, Wilt TJ. Kaka AS, et al. Ann Intern Med. 2022 May;175(5):701-709. doi: 10.7326/M21-4784. Epub 2022 Mar 1. Ann Intern Med. 2022. PMID: 35226522 Free PMC article.
Major Update 2: Remdesivir for Adults With COVID-19.
Finsterer J. Finsterer J. Ann Intern Med. 2022 Aug;175(8):W81. doi: 10.7326/L22-0211. Ann Intern Med. 2022. PMID: 35969872 No abstract available.